Dioseve Inc.

Dioseve has the technology to create oocytes from iPS cells, easily cheaply and unlimitedly. Uses of such technology include unprecedented infertility treatment methods, and it opens avenues for elucidating the cause of genetic diseases and establish a treatment as a groundbreaking therapy for various diseases using the induced oocytes.